Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Oncternal Therapeutics (ONCT) Insider Trading & Ownership

Oncternal Therapeutics logo

Oncternal Therapeutics (NASDAQ:ONCT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.20%
Number Of
Insiders Buying
(Last 3 Years)
3
Amount Of
Insider Buying
(Last 3 Years)
$102.57K
Number Of
Insiders Selling
(Last 3 Years)
0
Get ONCT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oncternal Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ONCT Insider Buying and Selling by Quarter

Oncternal Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/8/2024
Robert James Wills
Director
Buy3,086$8.96$27,650.56  
3/28/2024
Robert James Wills
Director
Buy6,914$8.48$58,630.72  
2/23/2024
David F Hale
David F Hale
Director
Buy714$9.04$6,454.56  
6/14/2023
Gunnar F Kaufmann
Insider
Buy150$7.20$1,080.00  
6/12/2023
Gunnar F Kaufmann
Insider
Buy1,250$7.00$8,750.00  
(Data available from 1/1/2013 forward)

ONCT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Oncternal Therapeutics includes David F Hale, Gunnar F Kaufmann, and Robert James Wills. Learn more on insiders at ONCT.

11.20% of Oncternal Therapeutics stock is owned by insiders. Learn more on ONCT's insider holdings.



This page (NASDAQ:ONCT) was last updated on 5/30/2026 by MarketBeat.com Staff.
From Our Partners